Literature DB >> 35080370

Enhanced Chemodynamic Therapy by Cu-Fe Peroxide Nanoparticles: Tumor Microenvironment-Mediated Synergistic Fenton Reaction.

Sagang Koo1,2, Ok Kyu Park1,3, Jonghoon Kim1,2, Sang Ihn Han1,2, Tae Yong Yoo1,2, Nohyun Lee1,4, Young Geon Kim1,2, Hyunjoong Kim1,2, Chaehong Lim1,2, Jong-Seong Bae5, Jin Yoo6, Dokyoon Kim1,7, Seung Hong Choi1,3, Taeghwan Hyeon1,2.   

Abstract

An urgent need in chemodynamic therapy (CDT) is to achieve high Fenton catalytic efficiency at small doses of CDT agents. However, simple general promotion of the Fenton reaction increases the risk of damaging normal cells along with the cancer cells. Therefore, a tailored strategy to selectively enhance the Fenton reactivity in tumors, for example, by taking advantage of the characteristics of the tumor microenvironment (TME), is in high demand. Herein, a heterogeneous CDT system based on copper-iron peroxide nanoparticles (CFp NPs) is designed for TME-mediated synergistic therapy. CFp NPs degrade under the mildly acidic conditions of TME, self-supply H2O2, and the released Cu and Fe ions, with their larger portions at lower oxidation states, cooperatively facilitate hydroxyl radical production through a highly efficient catalytic loop to achieve an excellent tumor therapeutic efficacy. This is distinct from previous heterogeneous CDT systems in that the synergism is closely coupled with the Cu+-assisted conversion of Fe3+ to Fe2+ rather than their independent actions. As a result, almost complete ablation of tumors at a minimal treatment dose is demonstrated without the aid of any other therapeutic modality. Furthermore, CFp NPs generate O2 during the catalysis and exhibit a TME-responsive T1 magnetic resonance imaging contrast enhancement, which are useful for alleviating hypoxia and in vivo monitoring of tumors, respectively.

Entities:  

Keywords:  Fenton reaction; antitumor agents; cancer; chemodynamic therapy; hypoxia; tumor microenvironment

Mesh:

Substances:

Year:  2022        PMID: 35080370     DOI: 10.1021/acsnano.1c09171

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  4 in total

1.  Nanozyme Hydrogels for Self-Augmented Sonodynamic/Photothermal Combination Therapy.

Authors:  Shuntao Wang; Ning Zeng; Qi Zhang; Mingzhu Chen; Qinqin Huang
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

2.  Albumin-assembled copper-bismuth bimetallic sulfide bioactive nanosphere as an amplifier of oxidative stress for enhanced radio-chemodynamic combination therapy.

Authors:  Weiyong Tao; Zhan Tuo; Feige Wu; Ketao Mu; Cunjing Xu; Yuxiao Shi; Zeyu Sun; Yifan Wang; Yan Li; Zhenyu Zhong; Lei Zhou; Jianglin Wang; Jie Liu; Yingying Du; Shengmin Zhang
Journal:  Regen Biomater       Date:  2022-07-05

3.  Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation.

Authors:  Yu-Cheng Chin; Li-Xing Yang; Fei-Ting Hsu; Che-Wei Hsu; Te-Wei Chang; Hsi-Ying Chen; Linda Yen-Chien Chen; Zi Chun Chia; Chun-Hua Hung; Wu-Chou Su; Yi-Chun Chiu; Chih-Chia Huang; Mei-Yi Liao
Journal:  J Nanobiotechnology       Date:  2022-08-11       Impact factor: 9.429

4.  Cancer Cell Membrane Biomimetic Mesoporous Nanozyme System with Efficient ROS Generation for Antitumor Chemoresistance.

Authors:  Wenxue Tang; Xiang Li; Meng Lyu; Qinqin Huang
Journal:  Oxid Med Cell Longev       Date:  2022-10-07       Impact factor: 7.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.